OS Therapies
- | Biotech or pharma, therapeutic R&D
OST-HER2 Listeria monocytogenes PhIIb Trial enrolling in Osteosarcoma
OST-TDC - next generation Tunable Drug Conjugate delivery system with pH sensitive Si-Linkers, Versatile Ligands, and multiple payloads
Address
New YorkNew York
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}